Skip directly to Accessibility Notice
Menu
Contact

Related ETFs

BBH
VanEck Vectors Biotech ETF
SMH
VanEck Vectors Semiconductor ETF
BJK
VanEck Vectors Gaming ETF
RTH
VanEck Vectors Retail ETF
EVX
VanEck Vectors Environmental Services ETF

How to Purchase

Learn more
Individual Investors

Subscribe to email updates

Subscribe Now

Financial Professionals

PPH
VanEck Vectors Pharmaceutical ETF

Fund Description

VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

 
 

  • Fund Ticker

    PPH

  • Exchange

    NASDAQ

  • Commencement

    12/20/2011

  • ETF Structure

    Physical

  • Administrator

    Van Eck Associates

  • Custodian

    Bank of New York Mellon

  • Index Ticker

    MVPPHTR

  • Index Rebalancing

    Quarterly

 
as of 01/18/19

  • 30-Day SEC Yield1

    1.79%

  • Total Net Assets

    $237.7M

  • Number of Holdings

    25

  • Options

    Available

  • Gross Expense Ratio2

    0.40%

  • Net Expense Ratio/TER2

    0.35%

  • Distribution Frequency

    Quarterly

  • Next Distribution Date

    --

Key Points

Highly Liquid Companies 
Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume
Industry Leaders
Index methodology favors the largest companies in the industry
Global Scope 
Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation
 

Trading Information

  • Fund Ticker

    PPH

  • Index Total Return Ticker

    MVPPHTR

  • NAV

    PPHNV

  • Intraday NAV (IIV)4

    PPHIV

  • Shares Outstanding

    4,088,138

  • Estimated Cash

    PPHEU

  • Total Cash

    PPHTC

  • CUSIP

    92189F692

  • ISIN

    US92189F6925
Source: Bloomberg

Fees and Expenses2

  • Management Fee

    0.35%

  • Other Expenses

    0.05%

  • Gross Expense Ratio

    0.40%

  • Fee Waivers and
    Expense Reimbursement

    -0.05%

  • Net Expense Ratio/TER2

    0.35%
2Expenses for PPH are capped contractually at 0.35% until February 1, 2019. Cap excludes acquired fund fees and expenses, interest expense, trading expenses, taxes and extraordinary expenses.

Prices as of 01/18/19

NAV/
Last Price 		Volume
30-Day Avg./
Last Trading Day 		Daily Change
NAV/
Last Price 		YTD Change
NAV/
Last Price 		Premium/
Discount 		Prem/Discount
Distribution Charts 		NAV &
Prem/Discount
History 		NAV
Chart
PPH $58.14
$58.09		 74,279
14,443		 $0.46 / +0.80%
$0.41 / +0.71%		 +6.05%
+6.39%
 $-0.05
-0.09%

View All Indices View All ETFs Performance History: Average Annual Total Returns* (%)

1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) -12.30 -14.21 -5.66 -5.66 -3.62 2.65 -- 8.51
PPH (Share Price) -12.60 -14.54 -6.01 -6.01 -3.79 2.59 -- 8.59
MVPPHTR (Index) -11.96 -13.89 -5.54 -5.54 -3.55 2.68 -- 8.54
Performance Differential (NAV - Index) -0.34 -0.32 -0.12 -0.12 -0.07 -0.03 -- -0.03
1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) -12.30 -14.21 -5.66 -5.66 -3.62 2.65 -- 8.51
PPH (Share Price) -12.60 -14.54 -6.01 -6.01 -3.79 2.59 -- 8.59
MVPPHTR (Index) -11.96 -13.89 -5.54 -5.54 -3.55 2.68 -- 8.54
Performance Differential (NAV - Index) -0.34 -0.32 -0.12 -0.12 -0.07 -0.03 -- -0.03

*Returns less than one year are not annualized.

The table presents past performance which is no guarantee of future results and which may be lower or higher than current performance. Returns reflect temporary contractual fee waivers and/or expense reimbursements. Had the ETF incurred all expenses and fees, investment returns would have been reduced. Investment returns and ETF share values will fluctuate so that investors' shares, when redeemed, may be worth more or less than their original cost. ETF returns assume that dividends and capital gains distributions have been reinvested in the Fund at NAV.

The "Net Asset Value" (NAV) of a VanEck Vectors Exchange Traded Fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF 's intraday trading value. VanEck Vectors ETF investors should not expect to buy or sell shares at NAV.

Daily Holdings Top 10 Holdings (%)as of 12/31/18

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$) 		% of Net
Assets
Abbvie Inc
ABBV US
140,686
12,969,842 5.70
Glaxosmithkline Plc
GSK US
330,808
12,640,174 5.55
Eli Lilly & Co
LLY US
109,016
12,615,332 5.54
Novo Nordisk A/S
NVO US
270,916
12,481,100 5.48
Pfizer Inc
PFE US
282,266
12,320,911 5.41
Merck & Co Inc
MRK US
159,786
12,209,248 5.36
Astrazeneca Plc
AZN US
320,352
12,166,969 5.34
Novartis Ag
NVS US
141,437
12,136,709 5.33
Sanofi
SNY US
276,075
11,984,416 5.26
Johnson & Johnson
JNJ US
84,738
10,935,439 4.80
Top 10 Total (%) 53.77
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 12/31/18

  • Country

    % of Net Assets
  • ■

    UNITED STATES

    67.10
  • ■

    UNITED KINGDOM

    12.92
  • ■

    DENMARK

    5.48
  • ■

    SWITZERLAND

    5.33
  • ■

    FRANCE

    5.26
  • ■

    ISRAEL

    4.00
  • ■

    Other/Cash

    -0.10

Sector Weightings (%) as of 12/31/18

  • Sector

    % of Net Assets
  • ■

    Health Care

    100.1
  • ■

    Other/Cash

    -0.1